Published in Clin Pharmacokinet on January 19, 2017
Dexmedetomidine for LISA Procedure in Preterm Infants (DEXLISA) | NCT04820101
Dexmedetomidine Cycling and Sleep in the Pediatric ICU | NCT05003102
Sedation for Non-invasive Ventilation in Blunt Chest Trauma | NCT05175781
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA (2009) 10.24
Developmental pharmacology--drug disposition, action, and therapy in infants and children. N Engl J Med (2003) 7.51
The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology (2000) 5.51
Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg (2000) 5.30
Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA (2012) 4.13
Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology (1992) 4.04
The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology (2003) 3.19
A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats. Anesthesiology (1992) 2.74
Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol (1988) 2.72
Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology (1992) 2.66
Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers. Anesthesiology (1998) 2.44
Effect of perioperative systemic α2 agonists on postoperative morphine consumption and pain intensity: systematic review and meta-analysis of randomized controlled trials. Anesthesiology (2012) 2.33
Dexmedetomidine pharmacodynamics: part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology (2004) 2.26
Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiology (2009) 2.24
Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther (2002) 2.23
Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive caret. Br J Anaesth (2002) 2.11
A general purpose pharmacokinetic model for propofol. Anesth Analg (2014) 2.09
Monitored anesthesia care with dexmedetomidine: a prospective, randomized, double-blind, multicenter trial. Anesth Analg (2009) 2.03
Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg (1997) 1.98
Effect of dexmedetomidine on haemodynamic responses to laryngoscopy and intubation : perioperative haemodynamics and anaesthetic requirements. Drugs R D (2006) 1.95
The effect of intravenously administered dexmedetomidine on perioperative hemodynamics and isoflurane requirements in patients undergoing abdominal hysterectomy. Anesthesiology (1991) 1.88
Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics (2009) 1.86
Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesth Analg (2008) 1.80
Glucuronidation in humans. Pharmacogenetic and developmental aspects. Clin Pharmacokinet (1999) 1.79
Non-shivering thermogenesis and brown adipose tissue in the human new-born infant. Nature (1965) 1.74
Central hypotensive effects of the alpha2a-adrenergic receptor subtype. Science (1996) 1.74
Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut (2002) 1.74
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. J Clin Anesth (2006) 1.71
Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients. Cochrane Database Syst Rev (2015) 1.67
The effects of dexmedetomidine on attenuation of stress response to endotracheal intubation in patients undergoing elective off-pump coronary artery bypass grafting. Ann Card Anaesth (2012) 1.67
A phase II/III, multicenter, safety, efficacy, and pharmacokinetic study of dexmedetomidine in preterm and term neonates. J Pediatr (2013) 1.67
Effects of a single pre-operative dexmedetomidine dose on isoflurane requirements and peri-operative haemodynamic stability. Anaesthesia (1997) 1.65
The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology (1993) 1.64
Attenuation of the ventilatory and heart rate responses to hypoxia and hypercapnia with aging in normal men. J Clin Invest (1973) 1.57
A randomised comparison of two intranasal dexmedetomidine doses for premedication in children. Anaesthesia (2012) 1.56
Systemically administered alpha2-agonist-induced peripheral vasoconstriction in humans. Anesthesiology (2003) 1.55
An updated focused review of dexmedetomidine in adults. Ann Pharmacother (2009) 1.53
Reduction of the minimum alveolar concentration of isoflurane by dexmedetomidine. Anesthesiology (1997) 1.52
Intranasal atomized dexmedetomidine for sedation during third molar extraction. Int J Oral Maxillofac Surg (2013) 1.50
Dexmedetomidine does not alter the sweating threshold, but comparably and linearly decreases the vasoconstriction and shivering thresholds. Anesthesiology (1997) 1.49
Bioavailability of dexmedetomidine after extravascular doses in healthy subjects. Br J Clin Pharmacol (2003) 1.42
Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care (2011) 1.40
A comparison of intranasal dexmedetomidine for sedation in children administered either by atomiser or by drops. Anaesthesia (2016) 1.40
Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery. Anesth Analg (2016) 1.39
The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg (2003) 1.34
A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. Am J Ther (2010) 1.33
Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology (1993) 1.30
Influence of race or ethnicity on pharmacokinetics of drugs. J Pharm Sci (1997) 1.24
Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients. Br J Anaesth (2012) 1.23
Comparative analgesic and mental effects of increasing plasma concentrations of dexmedetomidine and alfentanil in humans. Anesthesiology (2004) 1.20
Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East J Anaesthesiol (2007) 1.17
Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha 2 adrenergic receptor. Anesthesiology (1988) 1.16
Intranasal dexmedetomidine vs midazolam for premedication in children undergoing complete dental rehabilitation: a double-blinded randomized controlled trial. Paediatr Anaesth (2013) 1.15
A comparison of dexmedetomidine, and alpha 2-adrenoceptor agonist, and midazolam as i.m. premedication for minor gynaecological surgery. Br J Anaesth (1991) 1.15
The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment. Anesth Analg (2001) 1.15
Effect of dexmedetomidine on propofol requirements in healthy subjects. J Pharm Sci (2001) 1.14
Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats. Brain Res (2012) 1.13
Influence of cardiac output on dexmedetomidine pharmacokinetics. J Pharm Sci (2000) 1.13
Meta-analysis of factors which influence delirium following cardiac surgery. J Card Surg (2012) 1.13
Dexmedetomidine increases hippocampal phosphorylated extracellular signal-regulated protein kinase 1 and 2 content by an alpha 2-adrenoceptor-independent mechanism: evidence for the involvement of imidazoline I1 receptors. Anesthesiology (2008) 1.12
Bioavailability of dexmedetomidine after intranasal administration. Eur J Clin Pharmacol (2011) 1.12
The effect of dexmedetomidine sedation on brachial plexus block in patients with end-stage renal disease. Eur J Anaesthesiol (2009) 1.11
Dexmedetomidine pharmacokinetics in pediatric intensive care--a pooled analysis. Paediatr Anaesth (2009) 1.10
General anesthetics induce apoptotic neurodegeneration in the neonatal rat spinal cord. Anesth Analg (2008) 1.09
Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors. Anesthesiology (1989) 1.09
Intramuscular dexmedetomidine as premedication for general anesthesia. A comparative multicenter study. Anesthesiology (1993) 1.06
Does dexmedetomidine as a neuraxial adjuvant facilitate better anesthesia and analgesia? A systematic review and meta-analysis. PLoS One (2014) 1.06
Ethnic and genetic determinants of cardiovascular response to the selective alpha 2-adrenoceptor agonist dexmedetomidine. Hypertension (2007) 1.05
Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients. Crit Care (2011) 1.04
The effect of intravenous dexmedetomidine premedication on the dose requirement of propofol to induce loss of consciousness in patients receiving alfentanil. Anaesthesia (2001) 1.03
The effect of pre-anaesthetic administration of intravenous dexmedetomidine on postoperative pain in patients receiving patient-controlled morphine. Eur J Anaesthesiol (2005) 1.03
Clonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoceptor activation. Br J Pharmacol (2001) 1.00
The facilitatory effects of intravenous dexmedetomidine on the duration of spinal anesthesia: a systematic review and meta-analysis. Anesth Analg (2013) 0.98
Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects. J Clin Pharm Ther (2012) 0.97
Effect of systemic medetomidine, an alpha 2 adrenoceptor agonist, on experimental pain in humans. Anesthesiology (1991) 0.96
Central apnoea after balanced general anaesthesia that included dexmedetomidine. Br J Anaesth (2005) 0.95
Population pharmacokinetics of dexmedetomidine in infants after open heart surgery. Anesth Analg (2010) 0.94
Comparison of two dosing schedules of intravenous dexmedetomidine in elderly patients during spinal anesthesia. Korean J Anesthesiol (2014) 0.94
Alpha2-adrenoceptor agonists. Curr Opin Investig Drugs (2007) 0.94
Dexmedetomidine decreases thiopental dose requirement and alters distribution pharmacokinetics. Anesthesiology (1994) 0.94
Pharmacokinetics of dexmedetomidine in Chinese post-surgical intensive care unit patients. Acta Anaesthesiol Scand (2011) 0.93
Adequate sedation with single-dose dexmedetomidine in patients undergoing transurethral resection of the prostate with spinal anaesthesia: a dose-response study by age group. BMC Anesthesiol (2015) 0.93
Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes. Drug Metab Dispos (2008) 0.91
Comparison of Two Different Intranasal Doses of Dexmedetomidine in Children for Magnetic Resonance Imaging Sedation. Paediatr Drugs (2015) 0.90
IV and Perineural Dexmedetomidine Similarly Prolong the Duration of Analgesia after Interscalene Brachial Plexus Block: A Randomized, Three-arm, Triple-masked, Placebo-controlled Trial. Anesthesiology (2016) 0.89
Population pharmacokinetics of dexmedetomidine in critically ill patients. Clin Drug Investig (2013) 0.89
CYP2A6 genetic variation and dexmedetomidine disposition. Eur J Clin Pharmacol (2012) 0.88
The impact of perioperative dexmedetomidine infusion on postoperative narcotic use and duration of stay after laparoscopic bariatric surgery. J Gastrointest Surg (2007) 0.88
Rapid reversal of alpha 2-adrenoceptor agonist effects by atipamezole in human volunteers. Br J Clin Pharmacol (1991) 0.87
A comparative evaluation of intranasal dexmedetomidine, midazolam and ketamine for their sedative and analgesic properties: a triple blind randomized study. J Clin Pediatr Dent (2014) 0.87
Pharmacological effects and pharmacokinetics of atipamezole, a novel alpha 2-adrenoceptor antagonist--a randomized, double-blind cross-over study in healthy male volunteers. Br J Clin Pharmacol (1990) 0.87
Dexmedetomidine offers an option for safe and effective sedation for nuclear medicine imaging in children. Radiology (2013) 0.87
Neuronal ensembles sufficient for recovery sleep and the sedative actions of α2 adrenergic agonists. Nat Neurosci (2015) 0.86
Occurrence and predictors of dexmedetomidine infusion intolerance and failure. Hosp Pract (1995) (2012) 0.86
Pharmacokinetics and pharmacodynamics of transdermal dexmedetomidine. Eur J Clin Pharmacol (1994) 0.86
Effects of dexmedetomidine on hypoxia-evoked glutamate release and glutamate receptor activity in hippocampal slices. Anesthesiology (1996) 0.85
A randomized controlled trial of the effect of preoperative dexmedetomidine on the half maximal effective concentration of propofol for successful i-gel insertion without muscle relaxants. J Anesth (2014) 0.84
Perioperative dexmedetomidine for acute pain after abdominal surgery in adults. Cochrane Database Syst Rev (2016) 0.84
Dexmedetomidine can stabilize hemodynamics and spare anesthetics before cardiopulmonary bypass. J Anesth (2011) 0.83